SlideShare a Scribd company logo
1 of 16
Specifications for GMP
                Dietar y Supplements

                            A Presentation from
                                InstantGMP

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Dietary Supplements
          Orally ingested products that contain an
           ingredient that is intended to supplement
           the diet
          Not controlled by the FDA until 2007
          Now every manufacturer or distributor of
           dietary supplements has to be in
           compliance with Good Manufacturing
           Practices (GMP) requirements

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
                                                                                  2
Dietary Ingredients
       A ingredient intended to supplement the diet
       Could be one or more of:
             an amino acid
             a concentrate or extract of a plant material
             an herb or other botanical
             a mineral
             a vitamin
          “New Dietary Ingredient”
             Not sold in US before 1994
             FDA requires pre-market review


InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
GMP for Dietary Supplements
          FDA requires compliance in manufacturing, packaging,
           labeling, or holding operations
          Packaging and labeling has to be done per master
           manufacturing record
          Products must meet specifications for identity, purity,
           strength, and composition and limits on contaminants
          Demonstrate that product has been manufactured,
           packaged, labeled, and held under conditions to prevent
           adulteration
          All requirements for GMP compliance are in the FDA’s “Final
           Rule” on dietary supplements
          Does not apply to establishments that only manufacture
           dietary ingredients




InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Control Points
          Needed for any point where control in
           the manufacturing process ensures
           quality, for example:
             Heating steps
             Cooling steps
             Specific sanitation procedures to protect
              product
             Points where cross-contamination might
              occur
             Where environmental hygiene is necessary


InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Materials
          Specifications have to be established for
           all materials and components used in
           production
               Dietary ingredients (when received)
               In-process production materials
               Labels
               Packaging components
               Finished batch
               Product received from a supplier for
                packaging and labeling

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Production
          Specifications have to be established to
           prevent adulteration in manufacturing
           operations
             Critical equipment has to be cleaned and/or
              sanitized, then tested
             For example, eliminating possible microbial
              contamination that might be introduced by a
              raw material



InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications:
     Packaging/Labeling Firms
       Firms who perform labeling operations
        must establish specifications
       Ensure product received is adequately
        identified
       Ensure product is consistent with
        purchase order




InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Components
          Specifications needed for each component
           used in manufacturing
             Vitamins or minerals might include:
              ○ Identification
              ○ Assay
              ○ Appearance
              ○ Odor
              ○ Solubility
              ○ Melting Point
              ○ Loss on Drying or Residue on Ignition
              ○ Heavy Metals
              ○ Organic Volatile Impurities



InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Components
          Specifications needed for each
           component used in manufacturing
             Botanicals might include:
                ○ Identification such as visual comparison to
                    standard or picture
                ○   Part of the plant such as root or leaves
                ○   Color
                ○   Odor
                ○   Characteristics that differentiate the desired
                    species from related species

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Not Required
          Specifications are not needed for:
             Aesthetic appearance of dietary supplement
             Various constituents that are normally
              present in a natural product
             areas where scientific study is still evolving
                ○ Dissolution
                ○ Disintegration
                ○ Bioavailability




InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications: Exempted
          Specifications are exempted if you show that:
             The spec selected is not able to verify that the
              control system is producing a dietary supplement
              that is within that spec
             There is no scientifically valid method for testing or
              examining the exempted product spec at the finished
              batch stage
             You document why other information, such as
              component and in-process testing, will show the
              spec is met without finished batch testing for that
              spec



InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Specifications Parts:
       Test - Measurement of a quality attribute
        such as potency or water content
       Method - The procedure by which the
        quality attribute is measured
       Limit - The acceptable range for the
        attribute
       Other Requirements
             Safety and Handling
             Sampling Instructions

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
Quick Facts
          Developed by the manufacturing and
           quality experts at PharmaDirections
          Integrated internet based application
           developed through “Quality by Design”
           approach
          Standard Operating Procedures and
           Policies come with the application
          21 CFR Part 11 Compliant
          System has been in use since 2004


InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
InstantGMP™ Summary
          Electronic Batch Records for GMP manufacturing
          Takes full advantage of cloud-based application
          21 CFR Part 11 compliant database with SOP
           requirements hard coded into the software
          Streamlines entire process of producing GMP
           materials
          Simplifies the documentation and approval procedures
           to reduce production time lines
          Ideally suited for any GMP manufacturing such as
           APIs, drugs, OTCs, generics and dietary supplements
          For more information, contact:
             JPittman@InstantGMP.com
InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
InstantGMP™
                    www.instantgmp.com

             Electronic Batch Records
          System for GMP Manufacturing

InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations

More Related Content

What's hot

FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
 
Indian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationIndian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationVishal Shelke
 
GMP Dietary Supplement Manufacturing
GMP Dietary Supplement ManufacturingGMP Dietary Supplement Manufacturing
GMP Dietary Supplement ManufacturingInstantGMP™
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos ootAMOGH DANDEKAR
 
Quality by design
Quality by designQuality by design
Quality by designsuhasini
 
Ich – quality guidelines
Ich – quality guidelinesIch – quality guidelines
Ich – quality guidelinesHarishankar Sahu
 
Nutraceuticals ppt (1)
Nutraceuticals ppt (1)Nutraceuticals ppt (1)
Nutraceuticals ppt (1)sai sree
 
Stability studies ICH Q1A-Q1E Guidelines ppt
Stability studies ICH Q1A-Q1E Guidelines pptStability studies ICH Q1A-Q1E Guidelines ppt
Stability studies ICH Q1A-Q1E Guidelines pptAman K Dhamrait
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1priyanka odela
 
Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Atul Bhombe
 
Scope of Nutraceuticals
Scope of NutraceuticalsScope of Nutraceuticals
Scope of NutraceuticalsSanthiNori1
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravanshravan dubey
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 

What's hot (20)

FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...
 
ICH Guidelines
ICH GuidelinesICH Guidelines
ICH Guidelines
 
Indian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationIndian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP Certification
 
USFDA
USFDAUSFDA
USFDA
 
Usfda
UsfdaUsfda
Usfda
 
GMP Dietary Supplement Manufacturing
GMP Dietary Supplement ManufacturingGMP Dietary Supplement Manufacturing
GMP Dietary Supplement Manufacturing
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
Nutraceuticals
NutraceuticalsNutraceuticals
Nutraceuticals
 
Quality by design
Quality by designQuality by design
Quality by design
 
Ich – quality guidelines
Ich – quality guidelinesIch – quality guidelines
Ich – quality guidelines
 
Nutraceuticals ppt (1)
Nutraceuticals ppt (1)Nutraceuticals ppt (1)
Nutraceuticals ppt (1)
 
Stability studies ICH Q1A-Q1E Guidelines ppt
Stability studies ICH Q1A-Q1E Guidelines pptStability studies ICH Q1A-Q1E Guidelines ppt
Stability studies ICH Q1A-Q1E Guidelines ppt
 
Nutraceuticals
NutraceuticalsNutraceuticals
Nutraceuticals
 
Medical foods
Medical foodsMedical foods
Medical foods
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1
 
Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)Pharmaceutical development report (pdr)
Pharmaceutical development report (pdr)
 
Scope of Nutraceuticals
Scope of NutraceuticalsScope of Nutraceuticals
Scope of Nutraceuticals
 
PROCESS VALIDATION
PROCESS VALIDATIONPROCESS VALIDATION
PROCESS VALIDATION
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 

Viewers also liked

Dietary supplements
Dietary supplementsDietary supplements
Dietary supplementsNecola27
 
Instant GMP Compliance Series for Dietary Supplements – Introduction
Instant GMP Compliance Series for Dietary Supplements – IntroductionInstant GMP Compliance Series for Dietary Supplements – Introduction
Instant GMP Compliance Series for Dietary Supplements – IntroductionInstantGMP™
 
New Food Gcse Checklist Unit 1
New Food Gcse Checklist Unit 1New Food Gcse Checklist Unit 1
New Food Gcse Checklist Unit 1ciliar
 
Nital Resume - QA Batch record review 2014
Nital Resume - QA Batch record review 2014Nital Resume - QA Batch record review 2014
Nital Resume - QA Batch record review 2014Nital Rami
 
Finished pdt. release 112070804015
Finished pdt. release  112070804015Finished pdt. release  112070804015
Finished pdt. release 112070804015Patel Parth
 
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...MedicReS
 
Top 20 observation series # 3 21 CFR 211.192
Top 20 observation series # 3   21 CFR 211.192Top 20 observation series # 3   21 CFR 211.192
Top 20 observation series # 3 21 CFR 211.192Sathish Vemula
 
master formula record
master formula recordmaster formula record
master formula recordRohit K.
 
Gmp qa and doccumentation by kailash vilegave
Gmp qa and doccumentation by kailash vilegaveGmp qa and doccumentation by kailash vilegave
Gmp qa and doccumentation by kailash vilegaveKailash Vilegave
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Coursepiyush64173
 
PPS leisurecentrum Mijdrecht
PPS leisurecentrum MijdrechtPPS leisurecentrum Mijdrecht
PPS leisurecentrum Mijdrechtt_haagmans
 
Slide อุปกรณ์คอมพิวเตอร์
Slide อุปกรณ์คอมพิวเตอร์Slide อุปกรณ์คอมพิวเตอร์
Slide อุปกรณ์คอมพิวเตอร์Khemjira_P
 
Brian Fjeldsted "Social Media for Dealerships"
Brian Fjeldsted "Social Media for Dealerships"Brian Fjeldsted "Social Media for Dealerships"
Brian Fjeldsted "Social Media for Dealerships"Sean Bradley
 
Interntional finance 23aug 2
Interntional finance 23aug 2Interntional finance 23aug 2
Interntional finance 23aug 2Anuj Kumar Bajpai
 
Att bygga ett starkt varumärke i en digital värld. Hur gör man?
Att bygga ett starkt varumärke i en digital värld. Hur gör man?Att bygga ett starkt varumärke i en digital värld. Hur gör man?
Att bygga ett starkt varumärke i en digital värld. Hur gör man?LOVEATWORK
 

Viewers also liked (20)

Dietary supplements
Dietary supplementsDietary supplements
Dietary supplements
 
Instant GMP Compliance Series for Dietary Supplements – Introduction
Instant GMP Compliance Series for Dietary Supplements – IntroductionInstant GMP Compliance Series for Dietary Supplements – Introduction
Instant GMP Compliance Series for Dietary Supplements – Introduction
 
New Food Gcse Checklist Unit 1
New Food Gcse Checklist Unit 1New Food Gcse Checklist Unit 1
New Food Gcse Checklist Unit 1
 
Nital Resume - QA Batch record review 2014
Nital Resume - QA Batch record review 2014Nital Resume - QA Batch record review 2014
Nital Resume - QA Batch record review 2014
 
Finished pdt. release 112070804015
Finished pdt. release  112070804015Finished pdt. release  112070804015
Finished pdt. release 112070804015
 
Capacitacion norma gmp+fsA
Capacitacion norma gmp+fsACapacitacion norma gmp+fsA
Capacitacion norma gmp+fsA
 
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...
FDA 2013 Clinical Investigator Training Course: CMC and Investigator Brochure...
 
Top 20 observation series # 3 21 CFR 211.192
Top 20 observation series # 3   21 CFR 211.192Top 20 observation series # 3   21 CFR 211.192
Top 20 observation series # 3 21 CFR 211.192
 
master formula record
master formula recordmaster formula record
master formula record
 
Gmp qa and doccumentation by kailash vilegave
Gmp qa and doccumentation by kailash vilegaveGmp qa and doccumentation by kailash vilegave
Gmp qa and doccumentation by kailash vilegave
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Course
 
Egypt for world well being
Egypt for world well beingEgypt for world well being
Egypt for world well being
 
PPS leisurecentrum Mijdrecht
PPS leisurecentrum MijdrechtPPS leisurecentrum Mijdrecht
PPS leisurecentrum Mijdrecht
 
Sistema informació osal
Sistema informació osalSistema informació osal
Sistema informació osal
 
Om google docs
Om google docsOm google docs
Om google docs
 
Fortluz 2012
Fortluz 2012Fortluz 2012
Fortluz 2012
 
Slide อุปกรณ์คอมพิวเตอร์
Slide อุปกรณ์คอมพิวเตอร์Slide อุปกรณ์คอมพิวเตอร์
Slide อุปกรณ์คอมพิวเตอร์
 
Brian Fjeldsted "Social Media for Dealerships"
Brian Fjeldsted "Social Media for Dealerships"Brian Fjeldsted "Social Media for Dealerships"
Brian Fjeldsted "Social Media for Dealerships"
 
Interntional finance 23aug 2
Interntional finance 23aug 2Interntional finance 23aug 2
Interntional finance 23aug 2
 
Att bygga ett starkt varumärke i en digital värld. Hur gör man?
Att bygga ett starkt varumärke i en digital värld. Hur gör man?Att bygga ett starkt varumärke i en digital värld. Hur gör man?
Att bygga ett starkt varumärke i en digital värld. Hur gör man?
 

Similar to Specifications for GMP Dietary Supplements

What are Dietary Supplements?
What are Dietary Supplements?What are Dietary Supplements?
What are Dietary Supplements?InstantGMP™
 
What is GMP in India?
What is GMP in India?What is GMP in India?
What is GMP in India?InstantGMP™
 
Making GMP Materials in a Non-GMP Space
Making GMP Materials in a Non-GMP SpaceMaking GMP Materials in a Non-GMP Space
Making GMP Materials in a Non-GMP SpaceInstantGMP™
 
GMP Manufacturing for Worldwide Clinical Trials
GMP Manufacturing for Worldwide Clinical Trials GMP Manufacturing for Worldwide Clinical Trials
GMP Manufacturing for Worldwide Clinical Trials InstantGMP™
 
InstantGMP Compliance Series - Improving Specifications
InstantGMP Compliance Series - Improving SpecificationsInstantGMP Compliance Series - Improving Specifications
InstantGMP Compliance Series - Improving SpecificationsInstantGMP™
 
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...Instant GMP Compliance Series -Better Compliance through Master Manufacturing...
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...InstantGMP™
 
InstantGMP Compliance Series - Improving Quality through In-Process Control
InstantGMP Compliance Series - Improving Quality through In-Process ControlInstantGMP Compliance Series - Improving Quality through In-Process Control
InstantGMP Compliance Series - Improving Quality through In-Process ControlInstantGMP™
 
Instant GMP Compliance Series - Improving Documentation
Instant GMP Compliance Series - Improving DocumentationInstant GMP Compliance Series - Improving Documentation
Instant GMP Compliance Series - Improving DocumentationInstantGMP™
 
Instant GMP Compliance Series for Dietary Supplements – Cost of Compliance
Instant GMP Compliance Series for Dietary Supplements – Cost of ComplianceInstant GMP Compliance Series for Dietary Supplements – Cost of Compliance
Instant GMP Compliance Series for Dietary Supplements – Cost of ComplianceInstantGMP™
 
Gmp & its implementation sahil
Gmp & its implementation sahilGmp & its implementation sahil
Gmp & its implementation sahilsahilhusen
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing PracticesPrashant Tomar
 
InstantGMP Compliance Series - Improving Batch Production Records
InstantGMP Compliance Series - Improving Batch Production RecordsInstantGMP Compliance Series - Improving Batch Production Records
InstantGMP Compliance Series - Improving Batch Production RecordsInstantGMP™
 
InstantGMP Compliance Series - Testing
InstantGMP Compliance Series - TestingInstantGMP Compliance Series - Testing
InstantGMP Compliance Series - TestingInstantGMP™
 
Unit2 producing pharmaceutical-biopharmaceutical
Unit2 producing pharmaceutical-biopharmaceuticalUnit2 producing pharmaceutical-biopharmaceutical
Unit2 producing pharmaceutical-biopharmaceuticalmelodiekernahan
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glpMUSKANKr
 

Similar to Specifications for GMP Dietary Supplements (20)

What are Dietary Supplements?
What are Dietary Supplements?What are Dietary Supplements?
What are Dietary Supplements?
 
What is GMP in India?
What is GMP in India?What is GMP in India?
What is GMP in India?
 
Making GMP Materials in a Non-GMP Space
Making GMP Materials in a Non-GMP SpaceMaking GMP Materials in a Non-GMP Space
Making GMP Materials in a Non-GMP Space
 
GMP Manufacturing for Worldwide Clinical Trials
GMP Manufacturing for Worldwide Clinical Trials GMP Manufacturing for Worldwide Clinical Trials
GMP Manufacturing for Worldwide Clinical Trials
 
InstantGMP Compliance Series - Improving Specifications
InstantGMP Compliance Series - Improving SpecificationsInstantGMP Compliance Series - Improving Specifications
InstantGMP Compliance Series - Improving Specifications
 
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...Instant GMP Compliance Series -Better Compliance through Master Manufacturing...
Instant GMP Compliance Series -Better Compliance through Master Manufacturing...
 
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụngTiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
 
InstantGMP Compliance Series - Improving Quality through In-Process Control
InstantGMP Compliance Series - Improving Quality through In-Process ControlInstantGMP Compliance Series - Improving Quality through In-Process Control
InstantGMP Compliance Series - Improving Quality through In-Process Control
 
BatchMaster for Pharmaceuticals
BatchMaster for PharmaceuticalsBatchMaster for Pharmaceuticals
BatchMaster for Pharmaceuticals
 
Instant GMP Compliance Series - Improving Documentation
Instant GMP Compliance Series - Improving DocumentationInstant GMP Compliance Series - Improving Documentation
Instant GMP Compliance Series - Improving Documentation
 
Instant GMP Compliance Series for Dietary Supplements – Cost of Compliance
Instant GMP Compliance Series for Dietary Supplements – Cost of ComplianceInstant GMP Compliance Series for Dietary Supplements – Cost of Compliance
Instant GMP Compliance Series for Dietary Supplements – Cost of Compliance
 
Gmp & its implementation sahil
Gmp & its implementation sahilGmp & its implementation sahil
Gmp & its implementation sahil
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing Practices
 
InstantGMP Compliance Series - Improving Batch Production Records
InstantGMP Compliance Series - Improving Batch Production RecordsInstantGMP Compliance Series - Improving Batch Production Records
InstantGMP Compliance Series - Improving Batch Production Records
 
InstantGMP Compliance Series - Testing
InstantGMP Compliance Series - TestingInstantGMP Compliance Series - Testing
InstantGMP Compliance Series - Testing
 
GMP
GMPGMP
GMP
 
Unit2 producing pharmaceutical-biopharmaceutical
Unit2 producing pharmaceutical-biopharmaceuticalUnit2 producing pharmaceutical-biopharmaceutical
Unit2 producing pharmaceutical-biopharmaceutical
 
G m p 01
G m p 01G m p 01
G m p 01
 
GMP AND cGMP CONSIDERATIONS
GMP AND cGMP CONSIDERATIONSGMP AND cGMP CONSIDERATIONS
GMP AND cGMP CONSIDERATIONS
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
 

More from InstantGMP™

Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™
Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™
Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™InstantGMP™
 
Formulation Development of Poorly Soluble Drugs
Formulation Development of Poorly Soluble DrugsFormulation Development of Poorly Soluble Drugs
Formulation Development of Poorly Soluble DrugsInstantGMP™
 
InstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP™
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP™
 
InstantGMP Compliance Series - Facility Design
InstantGMP Compliance Series - Facility DesignInstantGMP Compliance Series - Facility Design
InstantGMP Compliance Series - Facility DesignInstantGMP™
 
InstantGMP Compliance Series - Equipment
InstantGMP Compliance Series - EquipmentInstantGMP Compliance Series - Equipment
InstantGMP Compliance Series - EquipmentInstantGMP™
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP™
 
InstantGMP Compliance Series - Supplier and Vendor Qualification
InstantGMP Compliance Series - Supplier and Vendor QualificationInstantGMP Compliance Series - Supplier and Vendor Qualification
InstantGMP Compliance Series - Supplier and Vendor QualificationInstantGMP™
 
InstantGMP Compliance Series - Managing Deviations for Improved Compliance
InstantGMP Compliance Series - Managing Deviations for Improved ComplianceInstantGMP Compliance Series - Managing Deviations for Improved Compliance
InstantGMP Compliance Series - Managing Deviations for Improved ComplianceInstantGMP™
 

More from InstantGMP™ (10)

Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™
Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™
Moving From Paper-Based Systems to Electronic Batch Records - InstantGMP™
 
InstantGMP MD
InstantGMP MDInstantGMP MD
InstantGMP MD
 
Formulation Development of Poorly Soluble Drugs
Formulation Development of Poorly Soluble DrugsFormulation Development of Poorly Soluble Drugs
Formulation Development of Poorly Soluble Drugs
 
InstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and RecallsInstantGMP Compliance Series - Complaints and Recalls
InstantGMP Compliance Series - Complaints and Recalls
 
InstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility AreasInstantGMP Compliance Series - Facility Areas
InstantGMP Compliance Series - Facility Areas
 
InstantGMP Compliance Series - Facility Design
InstantGMP Compliance Series - Facility DesignInstantGMP Compliance Series - Facility Design
InstantGMP Compliance Series - Facility Design
 
InstantGMP Compliance Series - Equipment
InstantGMP Compliance Series - EquipmentInstantGMP Compliance Series - Equipment
InstantGMP Compliance Series - Equipment
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and Labeling
 
InstantGMP Compliance Series - Supplier and Vendor Qualification
InstantGMP Compliance Series - Supplier and Vendor QualificationInstantGMP Compliance Series - Supplier and Vendor Qualification
InstantGMP Compliance Series - Supplier and Vendor Qualification
 
InstantGMP Compliance Series - Managing Deviations for Improved Compliance
InstantGMP Compliance Series - Managing Deviations for Improved ComplianceInstantGMP Compliance Series - Managing Deviations for Improved Compliance
InstantGMP Compliance Series - Managing Deviations for Improved Compliance
 

Recently uploaded

VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurVIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurSuhani Kapoor
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdfRenandantas16
 
A DAY IN THE LIFE OF A SALESMAN / WOMAN
A DAY IN THE LIFE OF A  SALESMAN / WOMANA DAY IN THE LIFE OF A  SALESMAN / WOMAN
A DAY IN THE LIFE OF A SALESMAN / WOMANIlamathiKannappan
 
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc.../:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...lizamodels9
 
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999Tina Ji
 
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024christinemoorman
 
rishikeshgirls.in- Rishikesh call girl.pdf
rishikeshgirls.in- Rishikesh call girl.pdfrishikeshgirls.in- Rishikesh call girl.pdf
rishikeshgirls.in- Rishikesh call girl.pdfmuskan1121w
 
GD Birla and his contribution in management
GD Birla and his contribution in managementGD Birla and his contribution in management
GD Birla and his contribution in managementchhavia330
 
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call GirlsCash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call GirlsApsara Of India
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Dave Litwiller
 
Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023Neil Kimberley
 
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts ServiceVip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Serviceankitnayak356677
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Eni 2024 1Q Results - 24.04.24 business.
Eni 2024 1Q Results - 24.04.24 business.Eni 2024 1Q Results - 24.04.24 business.
Eni 2024 1Q Results - 24.04.24 business.Eni
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMRavindra Nath Shukla
 
7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...Paul Menig
 
Insurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usageInsurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usageMatteo Carbone
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...lizamodels9
 

Recently uploaded (20)

VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service JamshedpurVIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
VIP Call Girl Jamshedpur Aashi 8250192130 Independent Escort Service Jamshedpur
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
 
Best Practices for Implementing an External Recruiting Partnership
Best Practices for Implementing an External Recruiting PartnershipBest Practices for Implementing an External Recruiting Partnership
Best Practices for Implementing an External Recruiting Partnership
 
A DAY IN THE LIFE OF A SALESMAN / WOMAN
A DAY IN THE LIFE OF A  SALESMAN / WOMANA DAY IN THE LIFE OF A  SALESMAN / WOMAN
A DAY IN THE LIFE OF A SALESMAN / WOMAN
 
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc.../:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...
/:Call Girls In Jaypee Siddharth - 5 Star Hotel New Delhi ➥9990211544 Top Esc...
 
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999
Russian Faridabad Call Girls(Badarpur) : ☎ 8168257667, @4999
 
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024
 
rishikeshgirls.in- Rishikesh call girl.pdf
rishikeshgirls.in- Rishikesh call girl.pdfrishikeshgirls.in- Rishikesh call girl.pdf
rishikeshgirls.in- Rishikesh call girl.pdf
 
GD Birla and his contribution in management
GD Birla and his contribution in managementGD Birla and his contribution in management
GD Birla and his contribution in management
 
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call GirlsCash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
 
Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023
 
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts ServiceVip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
 
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Eni 2024 1Q Results - 24.04.24 business.
Eni 2024 1Q Results - 24.04.24 business.Eni 2024 1Q Results - 24.04.24 business.
Eni 2024 1Q Results - 24.04.24 business.
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSM
 
7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...
 
Insurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usageInsurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usage
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
 

Specifications for GMP Dietary Supplements

  • 1. Specifications for GMP Dietar y Supplements A Presentation from InstantGMP InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 2. Dietary Supplements  Orally ingested products that contain an ingredient that is intended to supplement the diet  Not controlled by the FDA until 2007  Now every manufacturer or distributor of dietary supplements has to be in compliance with Good Manufacturing Practices (GMP) requirements InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations 2
  • 3. Dietary Ingredients  A ingredient intended to supplement the diet  Could be one or more of:  an amino acid  a concentrate or extract of a plant material  an herb or other botanical  a mineral  a vitamin  “New Dietary Ingredient”  Not sold in US before 1994  FDA requires pre-market review InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 4. GMP for Dietary Supplements  FDA requires compliance in manufacturing, packaging, labeling, or holding operations  Packaging and labeling has to be done per master manufacturing record  Products must meet specifications for identity, purity, strength, and composition and limits on contaminants  Demonstrate that product has been manufactured, packaged, labeled, and held under conditions to prevent adulteration  All requirements for GMP compliance are in the FDA’s “Final Rule” on dietary supplements  Does not apply to establishments that only manufacture dietary ingredients InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 5. Specifications: Control Points  Needed for any point where control in the manufacturing process ensures quality, for example:  Heating steps  Cooling steps  Specific sanitation procedures to protect product  Points where cross-contamination might occur  Where environmental hygiene is necessary InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 6. Specifications: Materials  Specifications have to be established for all materials and components used in production  Dietary ingredients (when received)  In-process production materials  Labels  Packaging components  Finished batch  Product received from a supplier for packaging and labeling InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 7. Specifications: Production  Specifications have to be established to prevent adulteration in manufacturing operations  Critical equipment has to be cleaned and/or sanitized, then tested  For example, eliminating possible microbial contamination that might be introduced by a raw material InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 8. Specifications: Packaging/Labeling Firms  Firms who perform labeling operations must establish specifications  Ensure product received is adequately identified  Ensure product is consistent with purchase order InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 9. Specifications: Components  Specifications needed for each component used in manufacturing  Vitamins or minerals might include: ○ Identification ○ Assay ○ Appearance ○ Odor ○ Solubility ○ Melting Point ○ Loss on Drying or Residue on Ignition ○ Heavy Metals ○ Organic Volatile Impurities InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 10. Specifications: Components  Specifications needed for each component used in manufacturing  Botanicals might include: ○ Identification such as visual comparison to standard or picture ○ Part of the plant such as root or leaves ○ Color ○ Odor ○ Characteristics that differentiate the desired species from related species InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 11. Specifications: Not Required  Specifications are not needed for:  Aesthetic appearance of dietary supplement  Various constituents that are normally present in a natural product  areas where scientific study is still evolving ○ Dissolution ○ Disintegration ○ Bioavailability InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 12. Specifications: Exempted  Specifications are exempted if you show that:  The spec selected is not able to verify that the control system is producing a dietary supplement that is within that spec  There is no scientifically valid method for testing or examining the exempted product spec at the finished batch stage  You document why other information, such as component and in-process testing, will show the spec is met without finished batch testing for that spec InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 13. Specifications Parts:  Test - Measurement of a quality attribute such as potency or water content  Method - The procedure by which the quality attribute is measured  Limit - The acceptable range for the attribute  Other Requirements  Safety and Handling  Sampling Instructions InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 14. Quick Facts  Developed by the manufacturing and quality experts at PharmaDirections  Integrated internet based application developed through “Quality by Design” approach  Standard Operating Procedures and Policies come with the application  21 CFR Part 11 Compliant  System has been in use since 2004 InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 15. InstantGMP™ Summary  Electronic Batch Records for GMP manufacturing  Takes full advantage of cloud-based application  21 CFR Part 11 compliant database with SOP requirements hard coded into the software  Streamlines entire process of producing GMP materials  Simplifies the documentation and approval procedures to reduce production time lines  Ideally suited for any GMP manufacturing such as APIs, drugs, OTCs, generics and dietary supplements  For more information, contact: JPittman@InstantGMP.com InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations
  • 16. InstantGMP™ www.instantgmp.com Electronic Batch Records System for GMP Manufacturing InstantGMP: Electronic Manufacturing System for Small Pharmaceutical Operations

Editor's Notes

  1. establish specifications for components (final Sec. 111.70(b)), in-process production (final Sec. 111.70(c)), labels and packaging (final Sec. 111.70(d)), the finished batch of dietary supplement (final Sec. 111.70(e)), product that you receive from a supplier for packaging and labeling (final Sec. 111.70(f)), and the packaging and labeling for the finished packaged and labeled dietary supplement include specifications necessary to prevent adulteration under section 402(a)(1), (a)(2), (a)(3), and (a)(4) of the act as a result of what the manufacturer may do or fail to do in its manufacturing operation, and not as a result of contaminants that are in or on the components received. For example, it may be critical that a certain piece of equipment be cleaned and/or sanitized after handling certain raw materials to ensure that there is no microbial contamination from microorganisms of public health significance to components processed on the equipment. If the manufacturer failed to establish a specification for cleaning and/or sanitizing after handling those raw materials before processing components, the manufacturer would have failed to establish a specification required by final Sec. specifications for identity, purity, strength, composition, and do not exceed their limits for contaminants. The identity, purity, strength, and composition, and the limits that you establish for contaminants, for a finished batch of dietary supplement are what we call ``product specifications' nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. persons who perform labeling operations are, in fact, subject to the final rule, including the requirements to establish specifications. if you receive a product from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier), you must establish specifications to ensure that the product that you receive is adequately identified and is consistent with your purchase order requires you to establish component specifications for each component you use in the manufacture of a dietary supplement. Under final Sec. 111.70(b)(1), you must establish an identity specification for each component that you use in the manufacture of a dietary supplement. A specification for identity may include more than one attribute. For example, a specification for the identity of a salt used in the manufacture of a vitamin and mineral supplement may include the physical characteristics of the solid (e.g., as a crystal or as a powder), the color, and the state of hydration (e.g., with two or three molecules of water). A specification for the identity of a botanical may include the part of the plant (e.g., roots or leaves), the color, and whether the part of the plant is in a native state or has been ground. Under final Sec. 111.70(b)(2), you must establish component specifications that are necessary to ensure that specifications for the purity, strength, and composition of dietary supplements manufactured using the components are met. Under final Sec. 111.70(b)(3) you must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch This identity specification is necessary to ensure that the finished dietary supplement meets its specification for identity because you could not know what your final product contains if you do not know what you put into it. For example, it is likely that you will need to establish a specification for the strength of vitamin C added as a component, that you use to make a multivitamin supplement, so that you will know how much vitamin C to add to satisfy the specification for the strength of the vitamin C in the final product. Thus, if you are manufacturing a vitamin C tablet with a strength of 50 milligrams (mg) per tablet, you must determine how much vitamin C, of a given strength, you must add in order to produce tablets that will contain 50 mg, after accounting for the theoretical yield at each step in the manufacturing process. However, you may not need to establish a specification for the strength of the tablet coating agent for that multivitamin supplement, if your final specifications include the amount of the tablet coating agent as part of the specifications for the composition, but not the strength of the multivitamin supplement. In most cases, a specification for the composition of the dietary supplement would be sufficient to ensure that the tablet coating agent is used within the established level. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  2. include specifications necessary to prevent adulteration under section 402(a)(1), (a)(2), (a)(3), and (a)(4) of the act as a result of what the manufacturer may do or fail to do in its manufacturing operation, and not as a result of contaminants that are in or on the components received. For example, it may be critical that a certain piece of equipment be cleaned and/or sanitized after handling certain raw materials to ensure that there is no microbial contamination from microorganisms of public health significance to components processed on the equipment. If the manufacturer failed to establish a specification for cleaning and/or sanitizing after handling those raw materials before processing components, the manufacturer would have failed to establish a specification required by final Sec. specifications for identity, purity, strength, composition, and do not exceed their limits for contaminants. The identity, purity, strength, and composition, and the limits that you establish for contaminants, for a finished batch of dietary supplement are what we call ``product specifications' nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. persons who perform labeling operations are, in fact, subject to the final rule, including the requirements to establish specifications. if you receive a product from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier), you must establish specifications to ensure that the product that you receive is adequately identified and is consistent with your purchase order requires you to establish component specifications for each component you use in the manufacture of a dietary supplement. Under final Sec. 111.70(b)(1), you must establish an identity specification for each component that you use in the manufacture of a dietary supplement. A specification for identity may include more than one attribute. For example, a specification for the identity of a salt used in the manufacture of a vitamin and mineral supplement may include the physical characteristics of the solid (e.g., as a crystal or as a powder), the color, and the state of hydration (e.g., with two or three molecules of water). A specification for the identity of a botanical may include the part of the plant (e.g., roots or leaves), the color, and whether the part of the plant is in a native state or has been ground. Under final Sec. 111.70(b)(2), you must establish component specifications that are necessary to ensure that specifications for the purity, strength, and composition of dietary supplements manufactured using the components are met. Under final Sec. 111.70(b)(3) you must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch This identity specification is necessary to ensure that the finished dietary supplement meets its specification for identity because you could not know what your final product contains if you do not know what you put into it. For example, it is likely that you will need to establish a specification for the strength of vitamin C added as a component, that you use to make a multivitamin supplement, so that you will know how much vitamin C to add to satisfy the specification for the strength of the vitamin C in the final product. Thus, if you are manufacturing a vitamin C tablet with a strength of 50 milligrams (mg) per tablet, you must determine how much vitamin C, of a given strength, you must add in order to produce tablets that will contain 50 mg, after accounting for the theoretical yield at each step in the manufacturing process. However, you may not need to establish a specification for the strength of the tablet coating agent for that multivitamin supplement, if your final specifications include the amount of the tablet coating agent as part of the specifications for the composition, but not the strength of the multivitamin supplement. In most cases, a specification for the composition of the dietary supplement would be sufficient to ensure that the tablet coating agent is used within the established level. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  3. nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. persons who perform labeling operations are, in fact, subject to the final rule, including the requirements to establish specifications. if you receive a product from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier), you must establish specifications to ensure that the product that you receive is adequately identified and is consistent with your purchase order requires you to establish component specifications for each component you use in the manufacture of a dietary supplement. Under final Sec. 111.70(b)(1), you must establish an identity specification for each component that you use in the manufacture of a dietary supplement. A specification for identity may include more than one attribute. For example, a specification for the identity of a salt used in the manufacture of a vitamin and mineral supplement may include the physical characteristics of the solid (e.g., as a crystal or as a powder), the color, and the state of hydration (e.g., with two or three molecules of water). A specification for the identity of a botanical may include the part of the plant (e.g., roots or leaves), the color, and whether the part of the plant is in a native state or has been ground. Under final Sec. 111.70(b)(2), you must establish component specifications that are necessary to ensure that specifications for the purity, strength, and composition of dietary supplements manufactured using the components are met. Under final Sec. 111.70(b)(3) you must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch This identity specification is necessary to ensure that the finished dietary supplement meets its specification for identity because you could not know what your final product contains if you do not know what you put into it. For example, it is likely that you will need to establish a specification for the strength of vitamin C added as a component, that you use to make a multivitamin supplement, so that you will know how much vitamin C to add to satisfy the specification for the strength of the vitamin C in the final product. Thus, if you are manufacturing a vitamin C tablet with a strength of 50 milligrams (mg) per tablet, you must determine how much vitamin C, of a given strength, you must add in order to produce tablets that will contain 50 mg, after accounting for the theoretical yield at each step in the manufacturing process. However, you may not need to establish a specification for the strength of the tablet coating agent for that multivitamin supplement, if your final specifications include the amount of the tablet coating agent as part of the specifications for the composition, but not the strength of the multivitamin supplement. In most cases, a specification for the composition of the dietary supplement would be sufficient to ensure that the tablet coating agent is used within the established level. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  4. nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. requires you to establish component specifications for each component you use in the manufacture of a dietary supplement. Under final Sec. 111.70(b)(1), you must establish an identity specification for each component that you use in the manufacture of a dietary supplement. A specification for identity may include more than one attribute. For example, a specification for the identity of a salt used in the manufacture of a vitamin and mineral supplement may include the physical characteristics of the solid (e.g., as a crystal or as a powder), the color, and the state of hydration (e.g., with two or three molecules of water). A specification for the identity of a botanical may include the part of the plant (e.g., roots or leaves), the color, and whether the part of the plant is in a native state or has been ground. Under final Sec. 111.70(b)(2), you must establish component specifications that are necessary to ensure that specifications for the purity, strength, and composition of dietary supplements manufactured using the components are met. Under final Sec. 111.70(b)(3) you must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch This identity specification is necessary to ensure that the finished dietary supplement meets its specification for identity because you could not know what your final product contains if you do not know what you put into it. For example, it is likely that you will need to establish a specification for the strength of vitamin C added as a component, that you use to make a multivitamin supplement, so that you will know how much vitamin C to add to satisfy the specification for the strength of the vitamin C in the final product. Thus, if you are manufacturing a vitamin C tablet with a strength of 50 milligrams (mg) per tablet, you must determine how much vitamin C, of a given strength, you must add in order to produce tablets that will contain 50 mg, after accounting for the theoretical yield at each step in the manufacturing process. However, you may not need to establish a specification for the strength of the tablet coating agent for that multivitamin supplement, if your final specifications include the amount of the tablet coating agent as part of the specifications for the composition, but not the strength of the multivitamin supplement. In most cases, a specification for the composition of the dietary supplement would be sufficient to ensure that the tablet coating agent is used within the established level. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  5. nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. Under final Sec. 111.70(b)(2), you must establish component specifications that are necessary to ensure that specifications for the purity, strength, and composition of dietary supplements manufactured using the components are met. Under final Sec. 111.70(b)(3) you must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch This identity specification is necessary to ensure that the finished dietary supplement meets its specification for identity because you could not know what your final product contains if you do not know what you put into it. For example, it is likely that you will need to establish a specification for the strength of vitamin C added as a component, that you use to make a multivitamin supplement, so that you will know how much vitamin C to add to satisfy the specification for the strength of the vitamin C in the final product. Thus, if you are manufacturing a vitamin C tablet with a strength of 50 milligrams (mg) per tablet, you must determine how much vitamin C, of a given strength, you must add in order to produce tablets that will contain 50 mg, after accounting for the theoretical yield at each step in the manufacturing process. However, you may not need to establish a specification for the strength of the tablet coating agent for that multivitamin supplement, if your final specifications include the amount of the tablet coating agent as part of the specifications for the composition, but not the strength of the multivitamin supplement. In most cases, a specification for the composition of the dietary supplement would be sufficient to ensure that the tablet coating agent is used within the established level. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  6. nonregulatory specifications include specifications that largely address the appearance of the dietary supplement in an aesthetic sense. this final rule does not require that you establish specifications for the identity, purity, strength, or composition of the various constituents that are inherently present in a natural product such as a botanical. However, the product specifications for the finished batch of a dietary supplement may include a specification, for example, of the strength of a substance that is present in the dietary supplement because it is a constituent of a natural product that you add as a component. For example, you may establish a specification for the amount of vitamin C in a dietary supplement that you manufacture by adding the component rose hips. If this is the case, then the component specifications for the natural product must include a specification for the strength of the constituent (e.g., vitamin C) in whatever amount you determine is necessary to meet the specification for the constituent (vitamin C) in the finished batch of dietary supplement. requires you, for in-process production, to provide adequate documentation of your basis for why meeting the in- process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for identity, purity, strength, and composition. requires that quality control personnel review and approve the documentation you provide. Meeting in-process specifications alone may not ensure the identity, purity, strength, or composition of the dietary supplement, but information about the component specification may be needed in order to put the results from the in-process specification in perspective. For example, if the manufacturer establishes a component specification for lead that it not be greater than ``x'' mg and establishes a specification that all piping that comes into contact with the component be lead free in the facility, and there are no other components or equipment that would be a source of lead, then there should be no added lead from processing, provided that the material only came in contact with the lead-free pipes and only the other lead-free components and equipment are used. Thus, we would not know by looking solely at the in-process specification whether the lead in the final product is not greater than ``x'' mg. You must select one or more established specifications for identity, purity, strength, composition, and limits on those types of contamination that may adulterate or that may lead to adulteration of the dietary supplement that, if tested or examined on the finished batch of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications (or only those product specifications not otherwise exempted from this provision by quality control personnel under final Sec. 111.75(d)); You may verify this by either testing or examining: (1) Every finished batch for each of these specifications or (2) a subset of finished batches for the dietary supplement. The subset of batches tested must be identified using a sound statistical sampling plan. If you choose to test or examine a subset of finished batches of dietary supplement, you may test or examine each subset of batches for identity, purity, strength, composition, and limits on contamination that you established. Alternatively, you may determine that you can select one, two, or three, or other number of these specifications that, if determined to be in compliance [[Page 34850]] with specifications, would be able to verify that the other untested specifications are met. tests for dissolution, disintegration, and bioavailability of dietary supplements are examples of areas where scientific study is still evolving; thus it is premature to impose requirements for such tests.
  7. you may exempt a product specification from the verification requirements of final Sec. 111.75(c)(1) if you show that: (1) The specifications selected to verify that the product meets all product specifications are not able to verify that the control system is producing a dietary supplement that meets the exempted product specification and (2) there is no scientifically valid method for testing or examining the exempted product specification at the finished batch stage. Final Sec. 111.75(c)(1) also requires you to document why other information, such as component and in-process testing, will determine whether the exempted product specification is met without finished batch testing. Although we agree that there may be some circumstances where there is not a scientifically valid method available for finished product testing, we believe that there would be some scientifically valid method available for component or in-process testing.